{
    "xml": "<topic id=\"PHP519\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/prednisolone\" basename=\"prednisolone\" title=\"PREDNISOLONE\">\n<title>PREDNISOLONE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_486\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/prednisolone\">Prednisolone</xref>\n</p>\n<data name=\"vtmid\">52388000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP40543\" outputclass=\"indicationsAndDose\" rev=\"1.77\" parent=\"/drugs/prednisolone\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Exacerbation of chronic obstructive pulmonary disease (if increased breathlessness interferes with daily activities)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30&#8239;mg daily for 7&#8211;14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe croup (before transfer to hospital)</p>\n<p outputclass=\"therapeuticIndication\">Mild croup that might cause complications (before transfer to hospital)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>1&#8211;2&#8239;mg/kg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate acute asthma (when oral corticosteroid taken for more than a few days)</p>\n<p outputclass=\"therapeuticIndication\">Severe or life-threatening acute asthma (when oral corticosteroid taken for more than a few days)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>2&#8239;mg/kg once daily (max. per dose 60&#8239;mg) for up to 3 days, longer if necessary.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate acute asthma</p>\n<p outputclass=\"therapeuticIndication\">Severe or life-threatening acute asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>1&#8211;2&#8239;mg/kg once daily (max. per dose 40&#8239;mg) for up to 3 days, longer if necessary.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>40&#8211;50&#8239;mg daily for at least 5 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8211;50&#8239;mg daily for at least 5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Local treatment of inflammation (short-term)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the eye</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply every 1&#8211;2&#8239;hours until controlled then reduce frequency.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply every 1&#8211;2&#8239;hours until controlled then reduce frequency.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8211;20&#8239;mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months; maintenance 2.5&#8211;15&#8239;mg daily, higher doses may be needed; cushingoid side-effects increasingly likely with doses above 7.5&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>25&#8211;100&#8239;mg 1&#8211;2 times a week, as prednisolone acetate.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders (initial dose in severe disease)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially up to 60&#8239;mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Idiopathic thrombocytopenic purpura</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;mg/kg daily, gradually reduce dose over several weeks.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Eczematous inflammation in otitis externa</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the ear</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 2&#8211;3&#8239;drops every 2&#8211;3&#8239;hours, frequency to be reduced when relief obtained.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 2&#8211;3&#8239;drops every 2&#8211;3&#8239;hours, frequency to be reduced when relief obtained.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Ulcerative colitis</p>\n<p outputclass=\"therapeuticIndication\">Crohn&#8217;s disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8211;40&#8239;mg daily until remission occurs, followed by reducing doses, up to 60&#8239;mg daily, may be used in some cases, doses preferably taken in the morning after breakfast.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Neuritic pain or weakness heralding rapid onset of permanent nerve damage (during reversal reactions multibacillary leprosy)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 40&#8211;60&#8239;mg daily, dose to be instituted at once.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Generalised myasthenia gravis (when given on alternate days)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;mg once daily on alternate days, then increased in steps of 10&#8239;mg once daily on alternate days, increased to 1&#8211;1.5&#8239;mg/kg once daily on alternate days (max. per dose 100&#8239;mg).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Generalised myasthenia gravis in ventilated patients (when given on alternate days)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1.5&#8239;mg/kg once daily on alternate days (max. per dose 100&#8239;mg).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Generalised myasthenia gravis (when giving daily)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;mg daily, increased in steps of 5&#8239;mg daily. maintenance 60&#8211;80&#8239;mg daily, alternatively maintenance 0.75&#8211;1&#8239;mg/kg daily, ventilated patients may be started on 1.5&#8239;mg/kg (max. 100&#8239;mg) on alternate days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Ocular myasthenia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Usual dose 10&#8211;40&#8239;mg once daily on alternate days, reduce to minimum effective dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Reduction in rate of joint destruction in moderate to severe rheumatoid arthritis of less than 2 years&#8217; duration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>7.5&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Polymyalgia rheumatica</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;15&#8239;mg daily until remission of disease activity; maintenance 7.5&#8211;10&#8239;mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Giant cell (temporal) arteritis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>40&#8211;60&#8239;mg daily until remission of disease activity, the higher dose being used if visual symptoms occur; maintenance 7.5&#8211;10&#8239;mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Polyarteritis nodosa</p>\n<p outputclass=\"therapeuticIndication\">Polymyositis</p>\n<p outputclass=\"therapeuticIndication\">Systemic lupus erythematosus</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 60&#8239;mg daily, then maintenance 10&#8211;15&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Anorexia (symptom control in palliative care)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8211;30&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Pneumocystis pneumonia in moderate to severe infections associated with HIV infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;80&#8239;mg daily for 5 days, the dose is then reduced to complete 21 days of treatment, corticosteroid treatment should ideally be started at the same time as the anti-pneumocystis therapy and certainly no later than 24&#8211;72 hours afterwards. The corticosteroid should be withdrawn before anti-pneumocystis treatment is complete.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Short-term prophylaxis of episodic cluster headache as monotherapy or in combination with verapamil during verapamil titration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>60&#8211;100&#8239;mg once daily for 2&#8211;5 days, then reduced in steps of 10&#8239;mg every 2&#8211;3&#8239;days until prednisolone is discontinued.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Proctitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By rectum using rectal foam</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20&#8239;mg prednisolone.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By rectum using suppositories</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Distal ulcerative colitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By rectum using rectal foam</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20&#8239;mg prednisolone.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Rectal complications of Crohn's disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By rectum using suppositories</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Rectal and rectosigmoidal ulcerative colitis</p>\n<p outputclass=\"therapeuticIndication\">Rectal and rectosigmoidal Crohn's disease</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By rectum using enema</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>20&#8239;mg daily for 2&#8211;4 weeks, continued if response good, to be used at bedtime.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40443\" outputclass=\"unlicensedUse\" rev=\"1.10\" parent=\"/drugs/prednisolone\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph> in children</p>\n<p>\n<i>Pred Forte</i>\n<tm tmtype=\"reg\"/> not licensed for use in children (age range not specified by manufacturer).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">rectal</ph> use in children</p>\n<p>Prednisolone rectal foam not licensed for use in children (age range not specified by manufacturer).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">ear</ph> in children</p>\n<p>Licensed for use in children (age range not specified by manufacturers).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40595\" outputclass=\"contraindications\" rev=\"1.21\" parent=\"/drugs/prednisolone\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"contraindication\">avoid alone in the presence of untreated infection (combine with suitable anti-infective)</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With rectal use</p>\n<p>\n<ph outputclass=\"contraindication\">bowel perforation</ph>; <ph outputclass=\"contraindication\">extensive fistulas</ph>; <ph outputclass=\"contraindication\">intestinal obstruction</ph>; <ph outputclass=\"contraindication\">recent intestinal anastomoses</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40604\" outputclass=\"cautions\" rev=\"1.31\" parent=\"/drugs/prednisolone\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"caution\">avoid prolonged use</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With rectal use</p>\n<p>\n<ph outputclass=\"caution\">systemic absorption may occur with rectal preparations</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With systemic use</p>\n<p>\n<ph outputclass=\"caution\">Duchenne&#8217;s muscular dystrophy (possible transient rhabdomyolysis and myoglobinuria following strenuous physical activity)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40472\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/prednisolone\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by ear</p>\n<p>\n<ph outputclass=\"sideEffect\">local sensitivity reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">When used by eye</p>\n<p>\n<ph outputclass=\"sideEffect\">adrenal suppression following prolonged use in neonates</ph> (in neonates); <ph outputclass=\"sideEffect\">corneal thinning</ph>; <ph outputclass=\"sideEffect\">scleral thinning</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40508\" outputclass=\"pregnancy\" parent=\"/drugs/prednisolone\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>As it crosses the placenta 88% of prednisolone is inactivated.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInPregnancy\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Pregnant women with fluid retention should be monitored closely.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40610\" outputclass=\"breastFeeding\" parent=\"/drugs/prednisolone\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Prednisolone appears in small amounts in breast milk but maternal doses of up to 40&#8239;mg daily are unlikely to cause systemic effects in the infant.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInBreastFeeding\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">systemic</ph> use</p>\n<p>Infant should be monitored for adrenal suppression if mother is taking a dose higher than 40&#8239;mg.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59621\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.10\" parent=\"/drugs/prednisolone\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">eye</ph>\n</p>\n<p>Although multi-dose prednisolone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40493\" outputclass=\"patientAndCarerAdvice\" rev=\"1.20\" parent=\"/drugs/prednisolone\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Prednisolone (oral) for nephrotic syndome</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome\">www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome</xref>\n</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Prednisolone for asthma</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/prednisolone-for-asthma\">www.medicinesforchildren.org.uk/prednisolone-for-asthma</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p>Patient counselling is advised for prednisolone tablets (steroid card).</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP519-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/prednisolone\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: eye drops, oral suspension, ear drops, oral solution, enema</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76532\" title=\"Tablet\" namespace=\"/drugs/prednisolone/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76096\" title=\"Soluble tablet\" namespace=\"/drugs/prednisolone/soluble-tablet\">Soluble tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76156\" title=\"Gastro-resistant tablet\" namespace=\"/drugs/prednisolone/gastro-resistant-tablet\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76912\" title=\"Oral solution\" namespace=\"/drugs/prednisolone/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76393\" title=\"Suspension for injection\" namespace=\"/drugs/prednisolone/suspension-for-injection\">Suspension for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76460\" title=\"Ear/eye drops solution\" namespace=\"/drugs/prednisolone/eareye-drops-solution\">Ear/eye drops solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76984\" title=\"Eye drops\" namespace=\"/drugs/prednisolone/eye-drops\">Eye drops</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76317\" title=\"Foam\" namespace=\"/drugs/prednisolone/foam\">Foam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76240\" title=\"Suppository\" namespace=\"/drugs/prednisolone/suppository\">Suppository</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76764\" title=\"Enema\" namespace=\"/drugs/prednisolone/enema\">Enema</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"1\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97233\" namespace=\"/guidance/prescribing-in-hepatic-impairment\" title=\"Prescribing in hepatic impairment\" count=\"1\" rel=\"backlink\">Prescribing in hepatic impairment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78123\" namespace=\"/treatment-summaries/-acute-medical-emergency\" title=\" acute, medical emergency\" count=\"5\" rel=\"backlink\"> acute, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78151\" namespace=\"/treatment-summaries/immune-response\" title=\"Immune response\" count=\"1\" rel=\"backlink\">Immune response</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78238\" namespace=\"/treatment-summaries/migraine\" title=\"Migraine\" count=\"1\" rel=\"backlink\">Migraine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78288\" namespace=\"/treatment-summaries/glucocorticoid-therapy\" title=\"Glucocorticoid therapy\" count=\"3\" rel=\"backlink\">Glucocorticoid therapy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78316\" namespace=\"/treatment-summaries/inflammatory-bowel-disease\" title=\"Inflammatory bowel disease\" count=\"3\" rel=\"backlink\">Inflammatory bowel disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78318\" namespace=\"/treatment-summaries/airways-disease-use-of-corticosteroids\" title=\"Airways disease, use of corticosteroids\" count=\"2\" rel=\"backlink\">Airways disease, use of corticosteroids</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78322\" namespace=\"/treatment-summaries/leprosy\" title=\"Leprosy\" count=\"1\" rel=\"backlink\">Leprosy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78360\" namespace=\"/treatment-summaries/asthma\" title=\"Asthma\" count=\"13\" rel=\"backlink\">Asthma</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78452\" namespace=\"/treatment-summaries/pneumocystis-pneumonia\" title=\"Pneumocystis pneumonia\" count=\"1\" rel=\"backlink\">Pneumocystis pneumonia</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78455\" namespace=\"/treatment-summaries/corticosteroids-inflammatory-disorders\" title=\"Corticosteroids, inflammatory disorders\" count=\"1\" rel=\"backlink\">Corticosteroids, inflammatory disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78505\" namespace=\"/treatment-summaries/neuromuscular-disorders\" title=\"Neuromuscular disorders\" count=\"2\" rel=\"backlink\">Neuromuscular disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78519\" namespace=\"/treatment-summaries/croup\" title=\"Croup\" count=\"1\" rel=\"backlink\">Croup</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78556\" namespace=\"/treatment-summaries/platelet-disorders\" title=\"Platelet disorders\" count=\"1\" rel=\"backlink\">Platelet disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78591\" namespace=\"/treatment-summaries/hormones-malignant-disease\" title=\"Hormones, malignant disease\" count=\"2\" rel=\"backlink\">Hormones, malignant disease</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_486\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/prednisolone\" title=\"Prednisolone\" count=\"1\" rel=\"link\">Prednisolone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76532\" namespace=\"/drugs/prednisolone/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76096\" namespace=\"/drugs/prednisolone/soluble-tablet\" title=\"Soluble tablet\" count=\"1\" rel=\"link\">Soluble tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76156\" namespace=\"/drugs/prednisolone/gastro-resistant-tablet\" title=\"Gastro-resistant tablet\" count=\"1\" rel=\"link\">Gastro-resistant tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76912\" namespace=\"/drugs/prednisolone/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76393\" namespace=\"/drugs/prednisolone/suspension-for-injection\" title=\"Suspension for injection\" count=\"1\" rel=\"link\">Suspension for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76460\" namespace=\"/drugs/prednisolone/eareye-drops-solution\" title=\"Ear/eye drops solution\" count=\"1\" rel=\"link\">Ear/eye drops solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76984\" namespace=\"/drugs/prednisolone/eye-drops\" title=\"Eye drops\" count=\"1\" rel=\"link\">Eye drops</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76317\" namespace=\"/drugs/prednisolone/foam\" title=\"Foam\" count=\"1\" rel=\"link\">Foam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76240\" namespace=\"/drugs/prednisolone/suppository\" title=\"Suppository\" count=\"1\" rel=\"link\">Suppository</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76764\" namespace=\"/drugs/prednisolone/enema\" title=\"Enema\" count=\"1\" rel=\"link\">Enema</xref>\n</links>\n</topic>",
    "id": "PHP519",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/prednisolone",
    "basename": "prednisolone",
    "title": "PREDNISOLONE",
    "interactants": [
        {
            "id": "bnf_int_486",
            "label": "Prednisolone"
        }
    ],
    "vtmid": "52388000",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (SYSTEMIC)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Exacerbation of chronic obstructive pulmonary disease (if increased breathlessness interferes with daily activities)",
                        "html": "Exacerbation of chronic obstructive pulmonary disease (if increased breathlessness interferes with daily activities)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "30 mg daily for 7&#8211;14 days.",
                        "html": "<p>30&#8239;mg daily for 7&#8211;14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe croup (before transfer to hospital)",
                        "html": "Severe croup (before transfer to hospital)"
                    },
                    {
                        "textContent": "Mild croup that might cause complications (before transfer to hospital)",
                        "html": "Mild croup that might cause complications (before transfer to hospital)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "1&#8211;2 mg/kg.",
                        "html": "<p>1&#8211;2&#8239;mg/kg.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate acute asthma (when oral corticosteroid taken for more than a few days)",
                        "html": "Mild to moderate acute asthma (when oral corticosteroid taken for more than a few days)"
                    },
                    {
                        "textContent": "Severe or life-threatening acute asthma (when oral corticosteroid taken for more than a few days)",
                        "html": "Severe or life-threatening acute asthma (when oral corticosteroid taken for more than a few days)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "2 mg/kg once daily (max. per dose 60 mg) for up to 3 days, longer if necessary.",
                        "html": "<p>2&#8239;mg/kg once daily (max. per dose 60&#8239;mg) for up to 3 days, longer if necessary.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate acute asthma",
                        "html": "Mild to moderate acute asthma"
                    },
                    {
                        "textContent": "Severe or life-threatening acute asthma",
                        "html": "Severe or life-threatening acute asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "1&#8211;2 mg/kg once daily (max. per dose 40 mg) for up to 3 days, longer if necessary.",
                        "html": "<p>1&#8211;2&#8239;mg/kg once daily (max. per dose 40&#8239;mg) for up to 3 days, longer if necessary.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "40&#8211;50 mg daily for at least 5 days.",
                        "html": "<p>40&#8211;50&#8239;mg daily for at least 5 days.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "40&#8211;50 mg daily for at least 5 days.",
                        "html": "<p>40&#8211;50&#8239;mg daily for at least 5 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Local treatment of inflammation (short-term)",
                        "html": "Local treatment of inflammation (short-term)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the eye"
                    ],
                    "textContent": "To the eye",
                    "html": "To the eye"
                },
                "child": [
                    {
                        "textContent": "Apply every 1&#8211;2 hours until controlled then reduce frequency.",
                        "html": "<p>Apply every 1&#8211;2&#8239;hours until controlled then reduce frequency.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply every 1&#8211;2 hours until controlled then reduce frequency.",
                        "html": "<p>Apply every 1&#8211;2&#8239;hours until controlled then reduce frequency.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders",
                        "html": "Suppression of inflammatory and allergic disorders"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 10&#8211;20 mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months; maintenance 2.5&#8211;15 mg daily, higher doses may be needed; cushingoid side-effects increasingly likely with doses above 7.5 mg daily.",
                        "html": "<p>Initially 10&#8211;20&#8239;mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months; maintenance 2.5&#8211;15&#8239;mg daily, higher doses may be needed; cushingoid side-effects increasingly likely with doses above 7.5&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "25&#8211;100 mg 1&#8211;2 times a week, as prednisolone acetate.",
                        "html": "<p>25&#8211;100&#8239;mg 1&#8211;2 times a week, as prednisolone acetate.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Suppression of inflammatory and allergic disorders (initial dose in severe disease)",
                        "html": "Suppression of inflammatory and allergic disorders (initial dose in severe disease)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially up to 60 mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months.",
                        "html": "<p>Initially up to 60&#8239;mg daily, dose preferably taken in the morning after breakfast, can often be reduced within a few days but may need to be continued for several weeks or months.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Idiopathic thrombocytopenic purpura",
                        "html": "Idiopathic thrombocytopenic purpura"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 mg/kg daily, gradually reduce dose over several weeks.",
                        "html": "<p>1&#8239;mg/kg daily, gradually reduce dose over several weeks.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Eczematous inflammation in otitis externa",
                        "html": "Eczematous inflammation in otitis externa"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the ear"
                    ],
                    "textContent": "To the ear",
                    "html": "To the ear"
                },
                "child": [
                    {
                        "textContent": "Apply 2&#8211;3 drops every 2&#8211;3 hours, frequency to be reduced when relief obtained.",
                        "html": "<p>Apply 2&#8211;3&#8239;drops every 2&#8211;3&#8239;hours, frequency to be reduced when relief obtained.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply 2&#8211;3 drops every 2&#8211;3 hours, frequency to be reduced when relief obtained.",
                        "html": "<p>Apply 2&#8211;3&#8239;drops every 2&#8211;3&#8239;hours, frequency to be reduced when relief obtained.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Ulcerative colitis",
                        "html": "Ulcerative colitis"
                    },
                    {
                        "textContent": "Crohn&#8217;s disease",
                        "html": "Crohn&#8217;s disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 20&#8211;40 mg daily until remission occurs, followed by reducing doses, up to 60 mg daily, may be used in some cases, doses preferably taken in the morning after breakfast.",
                        "html": "<p>Initially 20&#8211;40&#8239;mg daily until remission occurs, followed by reducing doses, up to 60&#8239;mg daily, may be used in some cases, doses preferably taken in the morning after breakfast.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Neuritic pain or weakness heralding rapid onset of permanent nerve damage (during reversal reactions multibacillary leprosy)",
                        "html": "Neuritic pain or weakness heralding rapid onset of permanent nerve damage (during reversal reactions multibacillary leprosy)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 40&#8211;60 mg daily, dose to be instituted at once.",
                        "html": "<p>Initially 40&#8211;60&#8239;mg daily, dose to be instituted at once.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Generalised myasthenia gravis (when given on alternate days)",
                        "html": "Generalised myasthenia gravis (when given on alternate days)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 mg once daily on alternate days, then increased in steps of 10 mg once daily on alternate days, increased to 1&#8211;1.5 mg/kg once daily on alternate days (max. per dose 100 mg).",
                        "html": "<p>Initially 10&#8239;mg once daily on alternate days, then increased in steps of 10&#8239;mg once daily on alternate days, increased to 1&#8211;1.5&#8239;mg/kg once daily on alternate days (max. per dose 100&#8239;mg).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Generalised myasthenia gravis in ventilated patients (when given on alternate days)",
                        "html": "Generalised myasthenia gravis in ventilated patients (when given on alternate days)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 1.5 mg/kg once daily on alternate days (max. per dose 100 mg).",
                        "html": "<p>Initially 1.5&#8239;mg/kg once daily on alternate days (max. per dose 100&#8239;mg).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Generalised myasthenia gravis (when giving daily)",
                        "html": "Generalised myasthenia gravis (when giving daily)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 5 mg daily, increased in steps of 5 mg daily. maintenance 60&#8211;80 mg daily, alternatively maintenance 0.75&#8211;1 mg/kg daily, ventilated patients may be started on 1.5 mg/kg (max. 100 mg) on alternate days.",
                        "html": "<p>Initially 5&#8239;mg daily, increased in steps of 5&#8239;mg daily. maintenance 60&#8211;80&#8239;mg daily, alternatively maintenance 0.75&#8211;1&#8239;mg/kg daily, ventilated patients may be started on 1.5&#8239;mg/kg (max. 100&#8239;mg) on alternate days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Ocular myasthenia",
                        "html": "Ocular myasthenia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Usual dose 10&#8211;40 mg once daily on alternate days, reduce to minimum effective dose.",
                        "html": "<p>Usual dose 10&#8211;40&#8239;mg once daily on alternate days, reduce to minimum effective dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Reduction in rate of joint destruction in moderate to severe rheumatoid arthritis of less than 2 years&#8217; duration",
                        "html": "Reduction in rate of joint destruction in moderate to severe rheumatoid arthritis of less than 2 years&#8217; duration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "7.5 mg daily.",
                        "html": "<p>7.5&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Polymyalgia rheumatica",
                        "html": "Polymyalgia rheumatica"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;15 mg daily until remission of disease activity; maintenance 7.5&#8211;10 mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.",
                        "html": "<p>10&#8211;15&#8239;mg daily until remission of disease activity; maintenance 7.5&#8211;10&#8239;mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Giant cell (temporal) arteritis",
                        "html": "Giant cell (temporal) arteritis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "40&#8211;60 mg daily until remission of disease activity, the higher dose being used if visual symptoms occur; maintenance 7.5&#8211;10 mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.",
                        "html": "<p>40&#8211;60&#8239;mg daily until remission of disease activity, the higher dose being used if visual symptoms occur; maintenance 7.5&#8211;10&#8239;mg daily, reduce gradually to maintenance dose. Many patients require treatment for at least 2 years and in some patients it may be necessary to continue long term low-dose corticosteroid treatment.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Polyarteritis nodosa",
                        "html": "Polyarteritis nodosa"
                    },
                    {
                        "textContent": "Polymyositis",
                        "html": "Polymyositis"
                    },
                    {
                        "textContent": "Systemic lupus erythematosus",
                        "html": "Systemic lupus erythematosus"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 60 mg daily, then maintenance 10&#8211;15 mg daily.",
                        "html": "<p>Initially 60&#8239;mg daily, then maintenance 10&#8211;15&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Anorexia (symptom control in palliative care)",
                        "html": "Anorexia (symptom control in palliative care)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "15&#8211;30 mg daily.",
                        "html": "<p>15&#8211;30&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Pneumocystis pneumonia in moderate to severe infections associated with HIV infection",
                        "html": "Pneumocystis pneumonia in moderate to severe infections associated with HIV infection"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;80 mg daily for 5 days, the dose is then reduced to complete 21 days of treatment, corticosteroid treatment should ideally be started at the same time as the anti-pneumocystis therapy and certainly no later than 24&#8211;72 hours afterwards. The corticosteroid should be withdrawn before anti-pneumocystis treatment is complete.",
                        "html": "<p>50&#8211;80&#8239;mg daily for 5 days, the dose is then reduced to complete 21 days of treatment, corticosteroid treatment should ideally be started at the same time as the anti-pneumocystis therapy and certainly no later than 24&#8211;72 hours afterwards. The corticosteroid should be withdrawn before anti-pneumocystis treatment is complete.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Short-term prophylaxis of episodic cluster headache as monotherapy or in combination with verapamil during verapamil titration",
                        "html": "Short-term prophylaxis of episodic cluster headache as monotherapy or in combination with verapamil during verapamil titration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "60&#8211;100 mg once daily for 2&#8211;5 days, then reduced in steps of 10 mg every 2&#8211;3 days until prednisolone is discontinued.",
                        "html": "<p>60&#8211;100&#8239;mg once daily for 2&#8211;5 days, then reduced in steps of 10&#8239;mg every 2&#8211;3&#8239;days until prednisolone is discontinued.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Proctitis",
                        "html": "Proctitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "rectum using suppositories"
                    ],
                    "textContent": "By rectum using suppositories",
                    "html": "By rectum using suppositories"
                },
                "adult": [
                    {
                        "textContent": "1 metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20 mg prednisolone.",
                        "html": "<p>1&#8239;metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20&#8239;mg prednisolone.</p>"
                    },
                    {
                        "textContent": "5 mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.",
                        "html": "<p>5&#8239;mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Distal ulcerative colitis",
                        "html": "Distal ulcerative colitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "rectum using rectal foam"
                    ],
                    "textContent": "By rectum using rectal foam",
                    "html": "By rectum using rectal foam"
                },
                "adult": [
                    {
                        "textContent": "1 metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20 mg prednisolone.",
                        "html": "<p>1&#8239;metered application 1&#8211;2 times a day for 2 weeks, continued for further 2 weeks if good response, to be inserted into the rectum, 1 metered application contains 20&#8239;mg prednisolone.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Rectal complications of Crohn's disease",
                        "html": "Rectal complications of Crohn's disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "rectum using suppositories"
                    ],
                    "textContent": "By rectum using suppositories",
                    "html": "By rectum using suppositories"
                },
                "adult": [
                    {
                        "textContent": "5 mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.",
                        "html": "<p>5&#8239;mg twice daily, to be inserted in to the rectum morning and night, after a bowel movement.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Rectal and rectosigmoidal ulcerative colitis",
                        "html": "Rectal and rectosigmoidal ulcerative colitis"
                    },
                    {
                        "textContent": "Rectal and rectosigmoidal Crohn's disease",
                        "html": "Rectal and rectosigmoidal Crohn's disease"
                    }
                ],
                "specificity": {
                    "routes": [
                        "rectum using enema"
                    ],
                    "textContent": "By rectum using enema",
                    "html": "By rectum using enema"
                },
                "adult": [
                    {
                        "textContent": "20 mg daily for 2&#8211;4 weeks, continued if response good, to be used at bedtime.",
                        "html": "<p>20&#8239;mg daily for 2&#8211;4 weeks, continued if response good, to be used at bedtime.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by eye in children",
                    "html": "When used by <ph outputclass=\"route\">eye</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Pred Forte not licensed for use in children (age range not specified by manufacturer).",
                "html": "<p>\n<i>Pred Forte</i>\n<tm tmtype=\"reg\"/> not licensed for use in children (age range not specified by manufacturer).</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With rectal use in children",
                    "html": "With <ph outputclass=\"route\">rectal</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "rectal"
                    ]
                },
                "textContent": "Prednisolone rectal foam not licensed for use in children (age range not specified by manufacturer).",
                "html": "<p>Prednisolone rectal foam not licensed for use in children (age range not specified by manufacturer).</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by ear in children",
                    "html": "When used by <ph outputclass=\"route\">ear</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "ear"
                    ]
                },
                "textContent": "Licensed for use in children (age range not specified by manufacturers).",
                "html": "<p>Licensed for use in children (age range not specified by manufacturers).</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid alone in the presence of untreated infection (combine with suitable anti-infective)",
                "html": "avoid alone in the presence of untreated infection (combine with suitable anti-infective)",
                "specificity": {
                    "textContent": "When used by ear",
                    "html": "When used by ear",
                    "routes": [
                        "ear"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "bowel perforation",
                "html": "bowel perforation",
                "specificity": {
                    "textContent": "With rectal use",
                    "html": "With rectal use",
                    "routes": [
                        "rectal"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "extensive fistulas",
                "html": "extensive fistulas",
                "specificity": {
                    "textContent": "With rectal use",
                    "html": "With rectal use",
                    "routes": [
                        "rectal"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "intestinal obstruction",
                "html": "intestinal obstruction",
                "specificity": {
                    "textContent": "With rectal use",
                    "html": "With rectal use",
                    "routes": [
                        "rectal"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "recent intestinal anastomoses",
                "html": "recent intestinal anastomoses",
                "specificity": {
                    "textContent": "With rectal use",
                    "html": "With rectal use",
                    "routes": [
                        "rectal"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid prolonged use",
                "html": "avoid prolonged use",
                "specificity": {
                    "textContent": "When used by ear",
                    "html": "When used by ear",
                    "routes": [
                        "ear"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "systemic absorption may occur with rectal preparations",
                "html": "systemic absorption may occur with rectal preparations",
                "specificity": {
                    "textContent": "With rectal use",
                    "html": "With rectal use",
                    "routes": [
                        "rectal"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "Duchenne&#8217;s muscular dystrophy (possible transient rhabdomyolysis and myoglobinuria following strenuous physical activity)",
                "html": "Duchenne&#8217;s muscular dystrophy (possible transient rhabdomyolysis and myoglobinuria following strenuous physical activity)",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With systemic use",
                    "routes": [
                        "systemic"
                    ]
                }
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "local sensitivity reactions",
                        "html": "local sensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by ear",
                            "html": "When used by ear",
                            "routes": [
                                "ear"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "adrenal suppression following prolonged use in neonates in neonates",
                        "html": "adrenal suppression following prolonged use in neonates in neonates",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ],
                            "patientType": "neonates"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "corneal thinning",
                        "html": "corneal thinning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "scleral thinning",
                        "html": "scleral thinning",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "When used by eye",
                            "html": "When used by eye",
                            "routes": [
                                "eye"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "As it crosses the placenta 88% of prednisolone is inactivated.",
                "html": "<p>As it crosses the placenta 88% of prednisolone is inactivated.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Pregnant women with fluid retention should be monitored closely.",
                "html": "<p>Pregnant women with fluid retention should be monitored closely.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Prednisolone appears in small amounts in breast milk but maternal doses of up to 40 mg daily are unlikely to cause systemic effects in the infant.",
                "html": "<p>Prednisolone appears in small amounts in breast milk but maternal doses of up to 40&#8239;mg daily are unlikely to cause systemic effects in the infant.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "specificity": {
                    "textContent": "With systemic use",
                    "html": "With <ph outputclass=\"route\">systemic</ph> use",
                    "routes": [
                        "systemic"
                    ]
                },
                "textContent": "Infant should be monitored for adrenal suppression if mother is taking a dose higher than 40 mg.",
                "html": "<p>Infant should be monitored for adrenal suppression if mother is taking a dose higher than 40&#8239;mg.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "When used by eye",
                    "html": "When used by <ph outputclass=\"route\">eye</ph>",
                    "routes": [
                        "eye"
                    ]
                },
                "textContent": "Although multi-dose prednisolone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.",
                "html": "<p>Although multi-dose prednisolone eye drops commonly contain preservatives, preservative-free unit dose vials may be available.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome",
                        "label": "www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Prednisolone (oral) for nephrotic syndome",
                "textContent": "www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome\">www.medicinesforchildren.org.uk/prednisolone-oral-for-nephrotic-syndrome</xref>\n</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/prednisolone-for-asthma",
                        "label": "www.medicinesforchildren.org.uk/prednisolone-for-asthma"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Prednisolone for asthma",
                "textContent": "www.medicinesforchildren.org.uk/prednisolone-for-asthma",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/prednisolone-for-asthma\">www.medicinesforchildren.org.uk/prednisolone-for-asthma</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patient counselling is advised for prednisolone tablets (steroid card).",
                "html": "<p>Patient counselling is advised for prednisolone tablets (steroid card).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "eye drops",
                "oral suspension",
                "ear drops",
                "oral solution",
                "enema"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76532",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76096",
                "label": "Soluble tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76156",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76912",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76393",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76460",
                "label": "Ear/eye drops solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76984",
                "label": "Eye drops",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76317",
                "label": "Foam",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76240",
                "label": "Suppository",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76764",
                "label": "Enema",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP97233",
                "label": "Prescribing in hepatic impairment",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78123",
                "label": "acute, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78151",
                "label": "Immune response",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78238",
                "label": "Migraine",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78288",
                "label": "Glucocorticoid therapy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78316",
                "label": "Inflammatory bowel disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78318",
                "label": "Airways disease, use of corticosteroids",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78322",
                "label": "Leprosy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78360",
                "label": "Asthma",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78452",
                "label": "Pneumocystis pneumonia",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78455",
                "label": "Corticosteroids, inflammatory disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78505",
                "label": "Neuromuscular disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78519",
                "label": "Croup",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78556",
                "label": "Platelet disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78591",
                "label": "Hormones, malignant disease",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_486",
                "label": "Prednisolone",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76532",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76096",
                "label": "Soluble tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76156",
                "label": "Gastro-resistant tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76912",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76393",
                "label": "Suspension for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76460",
                "label": "Ear/eye drops solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76984",
                "label": "Eye drops",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76317",
                "label": "Foam",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76240",
                "label": "Suppository",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76764",
                "label": "Enema",
                "type": "medicinalForm"
            }
        ]
    }
}